Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I8MT
|
||||
Former ID |
DNCL002767
|
||||
Drug Name |
Girentuximab
|
||||
Synonyms |
Rencarex (TN)
|
||||
Drug Type |
Antibody
|
||||
Company |
Wilex
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase IX | Target Info | [532748] | ||
KEGG Pathway | Nitrogen metabolism | ||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References | |||||
Ref 524178 | ClinicalTrials.gov (NCT01762592) REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT. U.S. National Institutes of Health. | ||||
Ref 542901 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7987). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.